214 related articles for article (PubMed ID: 16928714)
1. Reducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis.
Barlow G; Nathwani D; Williams F; Ogston S; Winter J; Jones M; Slane P; Myers E; Sullivan F; Stevens N; Duffey R; Lowden K; Davey P
Thorax; 2007 Jan; 62(1):67-74. PubMed ID: 16928714
[TBL] [Abstract][Full Text] [Related]
2. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.
Lee RW; Lindstrom ST
Respirology; 2007 Sep; 12(5):754-8. PubMed ID: 17875067
[TBL] [Abstract][Full Text] [Related]
3. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
[TBL] [Abstract][Full Text] [Related]
4. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
5. Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia.
Cortoos PJ; Gilissen C; Laekeman G; Peetermans WE; Leenaers H; Vandorpe L; Simoens S
Scand J Infect Dis; 2013 Mar; 45(3):219-26. PubMed ID: 23113827
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia.
Chalmers JD; Singanayagam A; Akram AR; Choudhury G; Mandal P; Hill AT
J Antimicrob Chemother; 2011 Feb; 66(2):416-23. PubMed ID: 21081545
[TBL] [Abstract][Full Text] [Related]
7. Management of community-acquired pneumonia by trained family general practitioners.
Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S
Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
[TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness analysis of ambulatory treatment for adult patients with community-acquired pneumonia: according to Japanese Respiratory Society guidelines].
Morimoto T; Koyama H; Shimbo T; Fukui T
Nihon Kokyuki Gakkai Zasshi; 2002 Jan; 40(1):17-25. PubMed ID: 11925912
[TBL] [Abstract][Full Text] [Related]
9. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
Frei CR; Restrepo MI; Mortensen EM; Burgess DS
Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
[TBL] [Abstract][Full Text] [Related]
10. Impact of guidelines on outcome: the evidence.
Martínez R; Reyes S; Lorenzo MJ; Menéndez R
Semin Respir Crit Care Med; 2009 Apr; 30(2):172-8. PubMed ID: 19296417
[TBL] [Abstract][Full Text] [Related]
11. Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia.
Barlow G; Nathwani D; Myers E; Sullivan F; Stevens N; Duffy R; Davey P
J Antimicrob Chemother; 2008 Feb; 61(2):442-51. PubMed ID: 18065412
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
[TBL] [Abstract][Full Text] [Related]
13. Impact of postgraduate education on physician practice for community-acquired pneumonia.
Ikai H; Morimoto T; Shimbo T; Imanaka Y; Koike K
J Eval Clin Pract; 2012 Apr; 18(2):389-95. PubMed ID: 21208347
[TBL] [Abstract][Full Text] [Related]
14. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study.
Capelastegui A; España PP; Quintana JM; Gorordo I; Ortega M; Idoiaga I; Bilbao A
Clin Infect Dis; 2004 Oct; 39(7):955-63. PubMed ID: 15472846
[TBL] [Abstract][Full Text] [Related]
15. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
Lee RW; Lindstrom ST
Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
Marras TK; Nopmaneejumruslers C; Chan CK
Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
[TBL] [Abstract][Full Text] [Related]
17. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?
Nathwani D; Rubinstein E; Barlow G; Davey P
Clin Infect Dis; 2001 Mar; 32(5):728-41. PubMed ID: 11229840
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of clinical guideline implementation to improve the appropriateness of chest physiotherapy prescription among inpatients with community-acquired pneumonia.
Guessous I; Cornuz J; Stoianov R; Burnand B; Fitting JW; Yersin B; Lamy O
Respir Med; 2008 Sep; 102(9):1257-63. PubMed ID: 18619824
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
Lavoie F; Blais L; Castilloux AM; Scalera A; LeLorier J
Can J Clin Pharmacol; 2005; 12(2):e212-7. PubMed ID: 15998960
[TBL] [Abstract][Full Text] [Related]
20. Effect of a simple educational intervention on the hospital management of community-acquired pneumonia.
Serisier DJ; Bowler SD
Respirology; 2007 May; 12(3):389-93. PubMed ID: 17539843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
